Ann: Notice of Annual General Meeting/Proxy Form, page-9

It’s all good Ice. I have just noticed lately that you seem to be continually negative on our company and that is of course understandable and your prerogative. There is much that has gone wrong for Admedus or may have been mismanaged to date but I see a lot of positives right now that far outweigh the negative history.

Admedus is still a very risky and speculative stock but I am greatfull that the work / progress of the last two years is starting to manifest itself.

Some positives:

The deals that have been done in the last 12 months, the vote down of the SIO options, the wonderful results of the 3D valve (DurAVR - what a name) implanted in our first patient, excellent feedback from various advisory board members and other medical professionals, increased awareness of the properties of Adapt (reflected in the LeMaitre sale and the way they refer to the products), the prototype of our TAVR device, our new singular focus in structural heart repair, the fact that we don’t have a large sales team to fund, the fact that we also have a free shot at TMVR (a huge market) and received a $1 million milestone payment from 4C medical in the March quarter, the fact that our valve is unique in that it is virtually the same for SAVR and TAVR, FDA approval for a broader use of Adapt in Cardiac settings, the fact that we are in partnership discussions with major companies and finally the share price has doubled off its bottom recently and looks to have stabilised.

In summary:

I, like many other long term holders have had a hell of a ride with Admedus (soon to be Anteris Technologies Ltd) and I have learned a lot. I am still optimistic about the company and can see the progression we have made.

How it will ultimately turn out is anyone’s guess (but I am obviously positive or I would have sold out like many others over the years) but I have come this far and intend to support the company and hope to hold for another 5 to 10 years + all going well.

Not advice and DYOR - AHZ is a small cap speculative / risky Invesment with many potential outcomes (some awesome and some not so awesome). Please do your research.